Advertisement

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Topiramate (2 x 25 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Topamax®, Ortho-McNeil Neurologics, Inc.) in Fed, Healthy, Adult Subjects

05:22 EDT 20th May 2013 | BioPortfolio

Summary

- Objective:

- Compare the bioequivalence of a test topiramate formulation (Torrent Pharmaceuticals Limited) to an equivalent oral dose of the commercially available topiramate (Topamax®, Ortho-McNeil Neurologics, Inc.) in a test population of adult subjects under fed conditions.

- Clinical Design:

- Studies were Randomized, Two-Way Crossover, Single-Dose,Open-Label in healthy human adult subjects.

Study Design

N/A

Conditions

Healthy

Intervention

topiramate

Location

Gateway Medical Research, Inc.
St, Charles
Missouri
United States

Status

Completed

Source

Torrent Pharmaceuticals Limited

Results (where available)

View Results

Links

Medical and Biotech [MESH] Definitions

Clinical Trials [ 113 Associated Clinical Trials listed on BioPortfolio]

Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

The purpose of this study is to evaluate the tolerability, safety and efficacy of topiramate in infants with refractory partial onset seizures (POS).

A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy

The purpose of this study is to identify patient characteristics (such as baseline seizure frequency) that may predict effective doses of topiramate using just that one drug (monotherapy)...

Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults

The primary objective of this study is to describe the single- and multiple-dose pharmacokinetic profiles of two novel formulations of topiramate and commercially available immediate relea...

Topiramate to Reduce Cocaine Dependence

Cocaine addiction is a serious health problem with no available medical treatment for preventing relapse. Topiramate, a medication which lowers dopamine levels, may have the ability to dim...

Topiramate Treatment of Problem Drinkers

The purpose of this study is to evaluate the safety and efficacy of topiramate in reducing drinking and heavy drinking frequency in problem drinkers. We hypothesize that at a dosage of up...

PubMed Articles [ 92 Associated PubMed Articles listed on BioPortfolio]

Effects of topiramate on diabetes mellitus induced by streptozotocin in rats.

Topiramate currently approved for marketing as antiepileptic drug also possesses anti-diabetic activity. The aim of this study was to determine the antidiabetic effect of topiramate in a rat model of...

A simple, rapid and specific method for measurement of topiramate in human plasma by LC-MS/MS employing automated solid-phase extraction techniques: Application for bioequivalence study.

A rapid liquid chromatography coupled with ESI tandem mass spectrometry (LC-MS/MS) method was developed and validated for the quantification of topiramate in heparinized human plasma. The plasma sampl...

Nephrolithiasis in topiramate users.

Topiramate is a neuromodulatory agent increasingly prescribed for a number of neurological and non-neurological indications. Topiramate-treated patients are at risk for nephrolithiasis due to hypocitr...

Perimenstrual migraines and their response to preventive therapy with topiramate.

Introduction: Preventive treatment with topiramate is effective for overall reduction of migraine frequency, but there are few data regarding its efficacy on perimenstrual migraines. To determine whet...

Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials.

Topiramate was associated with weight loss in clinical trials. We summarize the evidence on the efficacy and safety of topiramate in the treatment of overweight/obesity. The databases Medline, Embase,...

More From BioPortfolio on "Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Topiramate (2 x 25 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Topamax®, Ortho-McNeil Neurologics, Inc.) in Fed, Healthy, Adult Subjects"

Search BioPortfolio:
Advertisement
Advertisement